THANK YOU FOR SUBSCRIBING
The financing will enable VitaminLab to invest even more in technology and expand sales and marketing into new growth areas.
FREMONT, CA: "VitaminLab's disruptive approach is revolutionizing the personalized nutrition industry, and we are thrilled to continue supporting its positive impact on consumer health," said Paul Geyer, CEO of Nimbus Synergies. "We are also excited to have DSM Venturing's support on this journey, sharing their knowledge and experience. VitaminLab has been extremely capital efficient to date, and we know these additional funds and resources will fuel even faster growth, making personalized supplementation accessible to more people."
Nimbus Synergies and DSM Venturing co-led a Series A investment round in Vitamin-One Formulas Ltd. (doing business as VitaminLab), a pioneer in completely tailored supplements to fit unique health needs. The financing's revenues will be put to use by VitaminLab to scale up its go-to-market operations in North America and develop its facilities and cutting-edge automated lines.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
A person's DNA, health history, and results of blood tests are just a few of the various data points taken into account by VitaminLab's novel, evidence-based methodology. The customized supplement is made from a comprehensive nutrient list of more than 200 premium ingredients utilizing a patented process and equipment. Through integrated healthcare practitioners, direct-to-consumer online sales, and partnerships with top health testing businesses, VitaminLab has experienced significant growth.
"Our mission is to redefine the status quo and unlock better health outcomes by transforming how we take vitamins through tailored and truly unique formulas," says Anton Solonnikov, CEO of VitaminLab. "This financing allows us to extend our leadership position by further investing in our technology and expanding our sales and marketing into the practitioner market and new areas of growth."
More in News